Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Soiken Holdings Inc
2385Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for pharmaceutical clinical research and epidemiology studies; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. The company was incorporated in 1994 and is headquartered in Toyonaka, Japan. Address: Senri Life Science Center, Toyonaka, Japan, 560-0082
Analytics
Zielpreis von Wall Street
92 445.3 JPYKGV
–Dividendenrendite
3.65 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 2385
Dividenden-Analyse 2385
Dividendenwachstum über 5 Jahre
150 %Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
20 %Verlauf der Dividende 2385
Bewertung der Aktie 2385
Finanzen 2385
Ergebnisse | 2019 | Dynamik |